CVS Health Corporation $CVS Shares Sold by Intrua Financial LLC

Intrua Financial LLC trimmed its holdings in shares of CVS Health Corporation (NYSE:CVS) by 14.0% during the second quarter, Holdings Channel.com reports. The firm owned 7,373 shares of the pharmacy operator’s stock after selling 1,200 shares during the quarter. Intrua Financial LLC’s holdings in CVS Health were worth $509,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of CVS. Avion Wealth boosted its holdings in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the 2nd quarter worth $30,000. Bell Investment Advisors Inc lifted its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC boosted its stake in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. Finally, ORG Partners LLC raised its position in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.22% of the company’s stock.

CVS Health Stock Down 1.7%

CVS stock opened at $77.86 on Friday. The firm has a market cap of $98.84 billion, a PE ratio of 204.90, a PEG ratio of 0.87 and a beta of 0.60. The company has a fifty day simple moving average of $77.70 and a 200 day simple moving average of $69.90. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period in the previous year, the company earned $1.09 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Tuesday. TD Cowen boosted their price target on shares of CVS Health from $99.00 to $100.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and lifted their price objective for the stock from $71.00 to $82.00 in a research report on Thursday, August 14th. Truist Financial restated a “buy” rating and issued a $95.00 target price (up previously from $92.00) on shares of CVS Health in a report on Thursday, October 30th. Finally, Wells Fargo & Company decreased their target price on CVS Health from $103.00 to $102.00 and set an “overweight” rating for the company in a research report on Thursday. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.